Author

Bryan D Smith

Deciphera Pharmaceuticals

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Conan G KinseyiD· 1 shared Daniel L Flynn· 1 shared Eric L SnyderiD· 1 shared Guillermina LozanoiD· 1 shared Kayla T O'Toole· 1 shared Madhumita Bogdan· 1 shared Mark R Silvis· 1 shared Martin McMahoniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Conan G KinseyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhibition of ULK1/2 and KRASG12C controls tumor growth in preclinical models of lung cancer

Phaedra C Ghazi, Kayla T O'Toole, Sanjana Srinivas Boggaram, Michael T Scherzer, Mark R Silvis, Yun Zhang, Madhumita Bogdan, Bryan D Smith, Guillermina Lozano, Daniel L Flynn, Eric L Snyder, Conan G Kinsey, Martin McMahon

This study shows that combining ULK1/2 inhibition with KRASG12C inhibitors reduces lung cancer growth in preclinical models.

bioRxiv · Feb 6, 2024Cancer Biology